|
Dorsolateral pontine tegmentum
|
|
ILX:0103502
|
3
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Dorsolateral prefrontal cortex
|
Part of prefrontal cortex. The dorsolateral prefrontal cortex (DL-PFC or DLPFC), according to a more restricted definition, is roughly equivalent to Brodmann areas 9 and 46. According to a broader definition DL-PFC consists of the lateral portions of Brodmann areas 9 – 12, of areas 45, 46, and the superior part of area 47. These regions mainly receive their blood supply from the middle cerebral artery. With respect to neurotransmitter systems, there is evidence that dopamine plays a particularly important role in DL-PFC.DL-PFC is connected to the orbitofrontal cortex, and to a variety of brain areas, which include the thalamus, parts of the basal ganglia (the dorsal caudate nucleus), the hippocampus, and primary and secondary association areas of neocortex, including posterior temporal, parietal, and occipital areas check dorsolateral prefrontal neocortex (http://purl.obolibrary.org/obo/UBERON_0009834).
|
ILX:0103503
|
9
|
scicrunch
|
06/23/2020
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Dorsolateral prefrontal cortex layer 1
|
Most superficial layer of the Dorsolateral Prefrontal Cortex (DLPFC).
|
ILX:0103504
|
5
|
scicrunch
|
06/23/2020
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Dorsolateral prefrontal cortex layer 2
|
Layer 2 of neocortex lying just deep to superficial layer 1 of dorsolateral prefrontal cortex.
|
ILX:0103505
|
6
|
scicrunch
|
06/23/2020
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Dorsolateral prefrontal cortex layer 3
|
Layer 3 of dorsolateral prefrontal cortex lying deep to the layer 2 and cytoarchitectonically defined by numerous small pyramidal neurons.
|
ILX:0103506
|
5
|
scicrunch
|
06/23/2020
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Dorsolateral prefrontal cortex layer 4
|
Layer 4 of dorsolateral prefrontal cortex lying deep to the external pyramidal layer and cytoarchitectonically defined by presence of small cells.
|
ILX:0103507
|
6
|
scicrunch
|
06/23/2020
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Dorsolateral prefrontal cortex layer 5
|
Layer 5 of dorsolateral prefrontal cortex lying deep to the internal granule cell layer 4 and cytoarchitectonically divisible into layers 5a and 5b. Layer 5a is characterized by the predominance of large pyramidal cell bodies. Layer 5b is pale in comparison.
|
ILX:0103508
|
6
|
scicrunch
|
06/23/2020
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Dorsolateral prefrontal cortex layer 6
|
Innermost layer of dorsolateral prefrontal cortex lying deep to the internal pyramidal cell layer 5. It is cytoarchitectonically defined in the DLPFC by cells of varying sizes. DLPFC layer 6a is characterized by more neurons and layer 6b has comparatively more glia.
|
ILX:0103509
|
6
|
scicrunch
|
06/23/2020
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Dorsolateral septum
|
Portion of tissue that grows in from the dorsolateral wall of the otic vesicle, forming a dorsolateral partition between the developing anterior and posterior semicircular canals.
|
ILX:0103510
|
5
|
scicrunch
|
06/23/2020
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Dorsolateral striatum
|
|
ILX:0103511
|
3
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Dorsomedial cortex
|
|
ILX:0103512
|
3
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Dorsomedial hypothalamic region
|
|
ILX:0103513
|
3
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Dorsomedial neurosecretory cell
|
|
ILX:0103514
|
3
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Dorsomedial nucleus of hypothalamus
|
The Dorsomedial hypothalamic nucleus is a nucleus of the hypothalamus. It is involved in feeding, drinking, and body weight regulation. [WP,unvetted].
|
ILX:0103515
|
11
|
scicrunch
|
11/30/2020
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Dorsomedial nucleus of the hypothalamus anterior part of ABA 2009
|
|
ILX:0103516
|
3
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Dorsomedial nucleus of the hypothalamus of ABA 2009
|
|
ILX:0103517
|
3
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Dorsomedial nucleus of the hypothalamus posterior part of ABA 2009
|
|
ILX:0103518
|
3
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Dorsomedial nucleus of the hypothalamus ventral part of ABA 2009
|
|
ILX:0103519
|
3
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Dorzolamide
|
Dorzolamide is a carbonic anhydrase inhibitor. It is used in ophthalmic solutions (Trusopt) to lower increased intraocular pressure in open-angle glaucoma and ocular hypertension. Pharmacology: Dorzolamide is topical carbonic anhydrase inhibitor. Dorzolamide is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to beta-blockers. Mechanism of action: Dorzolamide is a sulfonamide and a human carbonic anhydrase II inhibitor. Inhibition of carbonic anhydrase II in the ciliary processes of the eye decreases aqueous humor secretion, presumably by slowing the formation of bicarbonate ions with subsequent reduction in sodium and fluid transport. Drug type: Approved. Small Molecule. Drug category: Antihypertensive Agents. Carbonic Anhydrase Inhibitors
|
ILX:0103520
|
3
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Dose Calibration Factor
|
Factor that was used to scale this image from counts/sec to Bq/ml using a dose calibrator. The value shall be one if no dose calibration was applied.
|
ILX:0103521
|
4
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |